Amgen
Trade Amgen 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About AMGN
Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K.
AMGN Key Statistics
Stock Snapshot
With a market cap of 189.27B, Amgen(AMGN) trades at $351.88. The stock has a price-to-earnings ratio of 27.16 and currently yields dividends of 2.7%.
On 2026-01-28, Amgen(AMGN) stock moved within a range of $346.93 to $353.25. With shares now at $351.88, the stock is trading +1.4% above its intraday low and -0.4% below the session's peak.
Trading activity shows a volume of 3.27M, compared to an average daily volume of 2.94M.
Over the past 52 weeks, Amgen(AMGN) stock has traded between a high of $353.25 and a low of $261.43.
Over the past 52 weeks, Amgen(AMGN) stock has traded between a high of $353.25 and a low of $261.43.
AMGN News
If you are wondering whether Amgen's current share price lines up with its underlying value, you are not alone. This article is built to walk you through that q...
Amgen Inc (AMGN) announced an update on their ongoing clinical study. Claim 50% Off TipRanks Premium Unlock hedge fund-level data and powerful investing tools f...
UBS raised the firm’s price target on Amgen (AMGN) to $390 from $380 and keeps a Buy rating on the shares. The U.S. Pharmaceuticals and Biotechnology group is e...
Analyst ratings
48%
of 33 ratingsMore AMGN News
Sagebrush Health Services has filed a lawsuit in California Superior Court against Amgen Inc., alleging unlawful termination of 340B drug discounts and improper...
Advertisement Why the Sagebrush lawsuit matters for Amgen stock The new lawsuit from Sagebrush Health Services puts Amgen (AMGN) and its role in the 340B Drug...
Amgen (NASDAQ:AMGN) snapped six consecutive sessions of gains, as the company’s shares closed 0.66% lower at $344.78 on Friday. In the preceding six sessions,...
Sagebrush Health Services has filed a lawsuit against Amgen (NasdaqGS:AMGN), accusing the company of improperly ending discounted drug sales under the federal 3...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.